Amna Subhan Butt

Amna Subhan Butt

Auto-generated profile, based on publicly available information

Amna Subhan Butt

Section of Gastroenterology, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2021 in Hepatology International
Verified
Journal Article
Closed access
PDF file
NVNipun Verma
Nipun Verma
RDRadha Krishan Dhiman
Radha Krishan Dhiman
ACAshok Choudhury
Ashok Choudhury
STSunil Taneja
Sunil Taneja
ADAjay Duseja
Ajay Duseja
APAPASL ACLF Research Consortium (AARC) for APASL ACLF working Party
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party

1 January 2015 in Euroasian Journal of Hepato-Gastroenterology
Verified
Journal Article
Open access
ABAmna Subhan Butt
Amna Subhan Butt
Pakistan is among ten most populous countries in world. All sorts of hepatitis are highly prevalent in Pakistan. Due to lack of proper mechanisms to handle sewerage, disinfection and lack of clean water supply across the country, hepatitis A and E are endemic in Pakistan. Moreover, Pakistan ranked in intermediate prevalence zone for hepatitis B and C. Also, prevailing socioeconomic conditions, political statuses and unstable healthcare delivery system are not suitable for tackling further progression of hepatitis viruses and its complications. The notable factors related to epidemiology of different hepatitis viruses have been described in this communication. Butt AS. Epidemiology of Viral Hepatitis and Liver Diseases in Pakistan. Euroasian J Hepato-Gastroenterol 2015;5(1):43-48.

1 January 2010 in Euroasian Journal of Hepato-Gastroenterology
Verified
Journal Article
Open access
ABAmna Subhan Butt
Amna Subhan Butt
FSFatima Sharif
Fatima Sharif
Viral hepatitis is a major cause of morbidity and mortality worldwide and a rising cause for concern in Asian countries. Weather it is blood borne or water/food borne hepatotropic virus, increasing burden is alarming for Asian countries. In this review we have evaluated the existing data to estimate the burden of viral hepatitis in populations of all age groups nationwide, along with an assessment of the risk factors and preventive and management strategies currently employed in Pakistan. The aim of our work is to consolidate and supplement the present knowledge regarding viral hepatitis in light of past and present trends and to provide future direction to the existing health policies. Butt AS, Sharif F. Viral Hepatitis in Pakistan: Past, Present, and Future. Euroasian J Hepato-Gastroenterol 2016;6(1):70-81.

21 November 2017 in Virology Journal
Verified
Journal Article
Open access
PDF file
ASAnanta Shrestha
Ananta Shrestha
AAAnurag Adhikari
Anurag Adhikari
MBManjula Bhattarai
Manjula Bhattarai
RRRamanuj Rauniyar
Ramanuj Rauniyar
JDJose Debes
Jose Debes
BGBirendra Gupta
Birendra Gupta
Infection with the hepatitis E virus (HEV) can cause acute hepatitis in endemic areas in immune-competent hosts, as well as chronic infection in immune-compromised subjects in non-endemic areas. Most studies assessing HEV infection in HIV-infected populations have been performed in developed countries that are usually affected by HEV genotype 3. The objective of this study is to measure the prevalence and risk of acquiring HEV among HIV-infected individuals in Nepal. We prospectively evaluated 459 Human Immunodeficiency Virus (HIV)-positive individuals from Nepal, an endemic country for HEV, for seroprevalence of HEV and assessed risk factors associated with HEV infection. All individuals were on antiretroviral therapy and healthy blood donors were used as controls. We found a high prevalence of HEV IgG (39.4%) and HEV IgM (15.3%) in HIV-positive subjects when compared to healthy HIV-negative controls: 9.5% and 4.4%, respectively (OR: 6.17, 95% CI 4.42–8.61, p < 0.001 and OR: 3.7, 95% CI 2.35–5.92, p < 0.001, respectively). Individuals residing in the Kathmandu area showed a significantly higher HEV IgG seroprevalance compared to individuals residing outside of Kathmandu (76.8% vs 11.1%, OR: 30.33, 95% CI 18.02–51.04, p = 0.001). Mean CD4 counts, HIV viral load and presence of hepatitis B surface antigen correlated with higher HEV IgM rate, while presence of hepatitis C antibody correlated with higher rate of HEV IgG in serum. Overall, individuals with HEV IgM positivity had higher levels of alanine aminotransferase (ALT) than IgM negative subjects, suggesting active acute infection. However, no specific symptoms for hepatitis were identified. HIV-positive subjects living in Kathmandu are at higher risk of acquiring HEV infection as compared to the general population and to HIV-positive subjects living outside Kathmandu.

25 June 2021 in Hepatology International
Verified
Journal Article
Closed access
PDF file
NVNipun Verma
Nipun Verma
RDRadha Krishan Dhiman
Radha Krishan Dhiman
VSVirendra Singh
Virendra Singh
ADAjay Duseja
Ajay Duseja
STSunil Taneja
Sunil Taneja
APApasl Aclf Working Party
Apasl Aclf Working Party

8 April 2013 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
ABAmna Subhan Butt
Amna Subhan Butt
SHSaeed Hamid
Saeed Hamid
AWAshfaq Ahmad Wadalawala
Ashfaq Ahmad Wadalawala
MGMariam Ghufran
Mariam Ghufran
AJAmmar Asrar Javed
Ammar Asrar Javed
WJWasim Jafri
Wasim Jafri
HCC is the fifth most common cancer globally. Our study was conducted to (1)investigate the trends and clinico-pathological characteristics of Hepatocellular carcinoma among native South Asian patients in Pakistan, (2)to estimate the prevalence as well as the trends of viral marker negative HCC and (3) to compare the clinico-pathological, radiological characteristics, applicability of treatment at diagnosis and prognostic factors among patients with both viral marker negative and viral marker positive-HCC being consulted at Aga Khan University Hospital(AKUH), Karachi, Pakistan.